Variables No. of patients MGMT TP53 CDKN2A
    M U M U M U
Age              
≤40 years 25 17 8 8 17 9 16
>40 years 23 19 4 6 17 8 15
Position              
Frontal 31 24 7 10 21 13 18
Others 17 12 5 4 13 4 13
Grade & type            
III AOD 15 10 5 7 8 8 7
AOA 11 9 2 3 7 3 8
AE 3 1 2 0 3 0 3
AA 2 2 0 0 3 0 2
Total 31 22 9 10 21 11 20
IV- GB 17 14 3 4 13 6 11
Post-surgery treatment          
CT+RT 21 17 4 6 15 9 12
RT 9 7 2 3 6 1 8
No 18 12 6 5 11 7 11
Table 1: Patient characteristics (Age, Position, Grade, Histology type, and Treatment information) wise Individual Methylation status of MGMT, TP53 and CDKN2A.